Beijing Chunlizhengda Medical Instruments Co., Ltd., commonly referred to as Chunlizhengda, is a leading player in the medical device industry, headquartered in Beijing, China. Established in 2000, the company has made significant strides in the development and manufacturing of high-quality medical instruments, particularly in the fields of orthopaedics and minimally invasive surgery. Chunlizhengda's core product offerings include advanced surgical instruments and innovative medical solutions that cater to both domestic and international markets. Renowned for their precision and reliability, these products have positioned the company as a trusted name among healthcare professionals. With a commitment to research and development, Chunlizhengda continues to enhance its market presence, contributing to the advancement of medical technology and improving patient outcomes globally.
How does Beijing Chunlizhengda Medical Instruments Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Beijing Chunlizhengda Medical Instruments Co's score of 27 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Beijing Chunlizhengda Medical Instruments Co., Ltd., headquartered in China (CN), reported total carbon emissions of approximately 3,239,250 kg CO2e. This figure includes 19,370 kg CO2e from Scope 1 emissions, 3,216,900 kg CO2e from Scope 2 emissions, and 6,980 kg CO2e from Scope 3 emissions. The company’s emissions for 2021 were slightly lower, with total emissions of about 2,113,900 kg CO2e, comprising 10,910 kg CO2e in Scope 1, 2,092,900 kg CO2e in Scope 2, and 3,990 kg CO2e in Scope 3. Beijing Chunlizhengda has set ambitious climate commitments, aiming for a 35% reduction in CO2 emissions intensity by 2030. This target is based on their 2020 emissions intensity of 0.0243 tonnes of CO2 per RMB 10,000 in products, with a goal to reduce this to 0.0157% by 2030. This commitment applies to both Scope 1 and Scope 2 emissions, reflecting the company's proactive approach to mitigating its carbon footprint. The company has not reported any emissions data for 2020, indicating a potential gap in their historical emissions tracking. However, their current reduction targets demonstrate a clear commitment to sustainability and climate action within the medical instruments industry.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | |
---|---|---|
Scope 1 | 10,910 | 00,000 |
Scope 2 | 2,092,900 | 0,000,000 |
Scope 3 | 3,990 | 0,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beijing Chunlizhengda Medical Instruments Co is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.